Simulating atomic movement with QDX's Loong Wang
from Nucleate Singapore Pulse Hosted by Nucleate Singapore
Loong Wang is the CEO and Co-Founder of QDX, a company specializing in computational drug discovery using quantum mechanics and supercomputing. In this episode, Loong discusses his journey from supercomputing at the Australian National University to founding multiple startups in distributed computing and blockchain—before making a significant pivot to biotechnology. His deep dive into quantum chemistry aims to address complex drug discovery challenges by simulating atomic and molecular behaviors at a fundamental level. He also touches on the potential for quantum chemistry to revolutionize high-throughput screening methods that big pharmaceutical companies currently rely on, making these processes faster, cheaper, and more precise. He emphasizes understanding the nuances of biomedical problems and the need for a multidisciplinary approach in developing groundbreaking solutions. Host: John Joson NgEditors: Jessie Wong, John Joson Ng The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected]. 01:02 Introduction 06:16 Understanding Quantum Mechanics in Drug Discovery 18:53 Challenges in Biotech: Collaboration and Simulations 26:30 Entrepreneurship, IP Strategy, and Scaling Up 42:22 Advice for Non-Traditional Entrants to Biotech
Embed this episode
No transcript yet.